Faeth Therapeutics Inc (FTH)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2025 | 12-2024 | 09-2024 | 06-2024 | 03-2024 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -6,864 | -30,157 | -22,387 | -15,134 | -7,992 |
| Depreciation Amortization | 34 | 1,322 | 991 | 659 | 331 |
| Other Working Capital | -859 | -489 | -739 | -1,342 | -1,427 |
| Other Operating Activity | 595 | 4,654 | 3,257 | 2,409 | 1,472 |
| Operating Cash Flow | $-7,094 | $-24,670 | $-18,878 | $-13,408 | $-7,616 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 7,151 | 22,586 | 25,737 | 12,823 | 5,807 |
| PPE Investments | 40 | -146 | -146 | -146 | -37 |
| Investing Cash Flow | $7,191 | $22,440 | $25,591 | $12,677 | $5,770 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -211 | -811 | -604 | -400 | -199 |
| Other Financing Activity | -3 | 24 | 11 | 11 | -10 |
| Financing Cash Flow | $-214 | $-787 | $-593 | $-389 | $-209 |
| Beginning Cash Position | 9,994 | 13,011 | 13,011 | 13,011 | 13,011 |
| End Cash Position | 9,877 | 9,994 | 19,131 | 11,891 | 10,956 |
| Net Cash Flow | $-117 | $-3,017 | $6,120 | $-1,120 | $-2,055 |
| Free Cash Flow | |||||
| Operating Cash Flow | -7,094 | -24,670 | -18,878 | -13,408 | -7,616 |
| Capital Expenditure | N/A | -146 | -146 | -146 | -37 |
| Free Cash Flow | -7,094 | -24,816 | -19,024 | -13,554 | -7,653 |